Back
Exact Sciences Quote, Financials, Valuation and Earnings
Sponsored
EXAS
Sponsored
Elon's Secret "A.I. 2.0" Project
Click here now to discover how to claim a stake in Elon's "A.I. 2.0" project
Sell
35
EXAS
Exact Sciences
Last Price:
59.30
Seasonality Move:
20.38%
7 Day Trial
ALL ACCESS PASS
$
7
My #1 Coin is...
All the details are on the next page.Exact Sciences Price Quote
$59.30
+0.45 (+0.76%)
(Updated: April 29, 2024 at 2:50 PM ET)
Exact Sciences Key Stats
Sell
35
Exact Sciences (EXAS)
is a Sell
Day range:
$58.45 - $60.31
52-week range:
$56.05 - $100.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.26
P/B ratio:
3.4%
Volume:
2M
Avg. volume:
2.9M
1-year change:
-6.11%
Market cap:
$10.7B
Revenue:
$2.5B
EPS:
$-1.14
How Much Does Exact Sciences Make?
-
How Much Are Exact Sciences's Sales Annually?
EXAS Revenues are $2.5B -
How Much Profit Does Exact Sciences's Make A Year?
EXAS net income is -$204.1M
Is Exact Sciences Growing As A Company?
-
What Is Exact Sciences's Growth Rate Quarterly?
Quarterly YoY revenue growth is 0.17% -
What Is Exact Sciences's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Exact Sciences Stock Price Performance
-
Did Exact Sciences Stock Go Up Last Month?
Exact Sciences share price went down by -9.79% last month -
Did EXAS's Share Price Rise Over The Last Year?
EXAS share price fell by -6.11% over the past 1 year
What Is Exact Sciences 52-Week High & Low?
-
What Is Exact Sciences’s 52-Week High Share Price?
Exact Sciences has traded as high as $100.77 over the past 52 weeks -
What Is Exact Sciences’s 52-Week Low Share Price?
Exact Sciences has traded as low as $56.05 over the past 52 weeks
Exact Sciences Price To Free Cash Flow
-
Is Exact Sciences Stock Overvalued?
Exact Sciences is trading at a price to free cash flow ratio of 333.60 -
Is Exact Sciences Stock Undervalued?
Exact Sciences EV to Free Cash Flow ratio is 384.28 -
What Is Exact Sciences’s Price Earnings Growth Ratio?
EXAS PEG ratio is 0.00 -
Is Exact Sciences Trading At A Premium To Earnings?
Exact Sciences EV to EBIT ratio is 0.00
Is It Risky To Buy Exact Sciences?
-
How Much Debt Does Exact Sciences Have?
Total long term debt quarterly is $2.4B -
How Much Cash Does Exact Sciences Have?
Cash and short term investments quarterly total is $777.6M -
What Is Exact Sciences’s Book Value Per Share?
Book value per share is 17.34
Is Exact Sciences Cash Flow Positive?
-
What Is EXAS Cash Flow From Operations?
Cash flow from operations (TTM) is $156.1M -
What Is Exact Sciences’s Cash Flow From Financing?
Cash flow from financing (TTM) is $159.8M -
What Is Exact Sciences’s Cash Flow From Investing?
Cash flow from investing (TTM) is $49.7M
Exact Sciences Return On Invested Capital
-
Is Management Doing A Good Job?
EXAS return on invested capital is -3.77% -
What Is Exact Sciences Return On Assets?
ROA measures how assets are converting to revenues and is -3.21% -
What Is EXAS Return On Equity?
ROE is a measure of profitability and is -6.62%
Exact Sciences Earnings Date & Stock Price
-
What Is Exact Sciences's Stock Price Today?
A single share of EXAS can be purchased today for 58.85 -
What Is Exact Sciences’s Stock Symbol?
Exact Sciences trades on the nasdaq under the ticker symbol: EXAS -
When Is Exact Sciences’s Next Earnings Date?
The next quarterly earnings date for Exact Sciences is scheduled on May 8, 2024 -
When Is EXAS's next ex-dividend date?
Exact Sciences's next ex-dividend date is April 29, 2024 -
How To Buy Exact Sciences Stock?
You can buy Exact Sciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Exact Sciences Competitors
-
Who Are Exact Sciences's Competitors?
Below is a list of companies who compete with Exact Sciences or are related in some way:
Exact Sciences Dividend Yield
Data Unavailable
Exact Sciences Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | -19.8% |
Revenue: | 16.98% | 1.12% |
Analyst Recommendations
Buy Recommendations: | 17 |
---|---|
Hold Recommendations: | 2 |
Sell Recommendations: | 0 |
Price Target: | 89.37 |
Upside from Last Price: | 51.85% |